Cutis marmorata telangiectatica congenita and aberrant Mongolian spots: Type V phacomatosis pigmentovascularis or phacomatosis cesiomarmorata  by Du, Guilian et al.
CASE REPORTCutis marmorata telangiectatica congenita and
aberrant Mongolian spots: Type V phacomatosis
pigmentovascularis or phacomatosis cesiomarmorata
Guilian Du, BA,a Xiaomin Zhang, MS,b and Tangde Zhang, MSb










28Key words: Cutis marmorata telangiectatica congenital; Mongolian spots; phacomatosis; phacomatosis
cesiomarmorata; phacomatosis pigmentovascularis.Abbreviations used:
CMTC: Cutis marmorata telangiectatica congenita
PPV: Phacomatosis pigmentovascularisINTRODUCTION
The coexistence of cutis marmorata telangiecta-
tica congenita (CMTC) with Mongolian spots has
been reported as a distinct type of phacomatosis
pigmentovascularis (PPV), namely PPV type V or
phacomatosis cesiomarmorata.1,2 PPV type V is a
rare congenital vascular anomaly, with only 7
previous cases mentioned in the literature. Our
team conducted research on a newborn with CMTC
and aberrant Mongolian spots and reviewed the
literature.CASE REPORT
A purplish reticulated vascular network, phlebec-
tasia, and telangiectasia were observed at birth of a
female of 3913 gestational weeks, suggesting a
diagnosis of CMTC. The lesions were located on
the entire back, most of the buttocks, right half of the
front of the trunk (with a clear demarcation from the
unchanged skin right in the midline), right thigh, and
left knee (Fig 1). The lesion was made more distinct
when the baby was crying, during vigorous activity,
and when cold. Additionally, the hyperpigmented
patches, which were considered Mongolian spots,
partly intermingled with the lesions of CMTC, were
located on the right upper back, the mid-spine, and
the lumbosacral region (Fig 2). Extremities were
symmetrical, with no atrophy or hypertrophy of
soft tissue. The infant showed normal mental
and physical development. Her parents were not
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Regularly monitored laboratory, hematologic,
biochemical analysis and chromosomal microarray
detection were unremarkable. Histopathologic
examination on the right side of the thigh found
numerous dilated capillaries and venules in the
dermis (Fig 3).
Given the constellation of clinical findings, PPV
type V or phacomatosis cesiomarmorata was diag-
nosed. There are few cases reported in the literature
of this kind of PPV.
In a follow-up examination when the infant was
2 months old, her mother reported that the child’s
legs trembled occasionally with no obvious cause.
However, magnetic resonance imaging of the brain
was unremarkable. The skin changes of CMTC had
almost disappeared, while the Mongolian spots were
persistent (Fig 4).
DISCUSSION
PPV is a rare congenital vascular anomaly
characterized by the coexistence of vascular
malformation with melanocytic lesions, including
epidermal nevi and dermal melanocytosis. In 1985,
Hasegawa and Yasuhara3 proposed classifyingJAAD Case Reports 2016;2:28-30.
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Fig 1. Skin changes of a mature infant age 3 days.
Fig 2. Skin changes of a mature infant age 3 days.
Fig 3. Histopathologic examination shows numerous
dilated capillaries and venules in the dermis level.
A high-resolution version of this slide for use with the
Virtual Microscope is available as eSlide: VM01040.
Fig 4. Skin changes of a mature infant age 2 months.
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of a nevus flammeus and melanocytic lesion. Each
type is further classified as cutaneous disease only
(subtype a), or cutaneous with coexistent systemic
disease (subtype b). The combination of CMTC and
Mongolian spot, categorized as PPV type V, was
added in 2003.1
However, in 2005, Happle2 found that only 3
well-established types of PPV so far exist. He
considered that a categorical distinction of cases
with and without extracutaneous anomalies seemed
inappropriate and proposed a new classification of
PPV by using 3 descriptive terms: phacomatosis
cesioflammea (blue spots and nevus flammeus),
which is identical to the traditional type II;
phacomatosis spilorosea, which corresponds to
type III (nevus spilus coexisting with a pale-pink
telangiectatic nevus), and phacomatosis cesiomar-
morata (blue spots and cutis marmorata telangiecta-
tica congenita), which is a descriptive term for
type V. The subgroup of type I was eliminated, and
the extremely rare traditional type IV is included in
the group of unclassifiable forms.
The lesions of CMTC, which tend to show
a mosaic distribution in a patchy, quadrant, or
unilateral manner with a sharp demarcation at the
midline, support the hypothesis that CMTC is a
disorder to which the lethal gene survives bymosaicism.4 The pathogenesis of PPV is still un-
known. Seven cases of PPV type V (or phacomatosis
cesiomarmorata) have been published, of which, 4
cases1,5,6 were traditional type Vb, mostly with
ophthalmologic, cardiac, or brain impairment, and
3 cases7-9 were traditional type Va. It is interesting
that the patients with type Vb all mentioned that the
bluish spots and the vascular lesions faded slowly or
remained unchanged. Otherwise, most of the reports
of the traditional type Va did not report on follow-up.
Only 1 report of a case9 of traditional type Va
reported that both signs clearly diminished at a
controlled visit after 12 months. We suspected that,
in the patients with no association of systemic
disease, their symptoms diminished faster. In our
case, the lesions of CMTC almost disappeared in
2 months, which is faster than that of other cases,
most probably because of thinning and prematura-
tion of the lesions. It is not known if this has anything
to do with the cutaneous feature in different ethnic
groups, because 4 of 7 cases described in the
literature are from Spain. Some investigators found
differences between isolated nevi flammei and those
associated with PPV, and Hagiwara et al10 report
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acteristics in the nevi flammei of the PPV. We suspect
that there may have been differences between
isolated CMTC and those associated with PPV type
Va and Vb.
It is estimated that 50% of patients with PPV
present with systemic involvement. Most of the
studies are those associated with PPV type IIb, in
which Sturge-Weber syndrome and Klippel-
Trenaunay syndrome are the most common identifi-
able disorders, followed by central nervous system
dysfunction, epilepsy, renal agenesis, and hemangi-
oma.7 Most cases described in the literature are from
Japan, Mexico, or Argentina.
For many patients, PPV without systematic
complications is a benign condition and requires
no treatment. In some persistent lesions, such as
nevi flammei and mongolion spots, the cutaneous
abnormality may be improved by treating with
lasers.
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